ArticleHaematologica2025

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma.

Lorenzo Falchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.